scispace - formally typeset
E

Eline Slagboom

Researcher at Leiden University

Publications -  46
Citations -  2353

Eline Slagboom is an academic researcher from Leiden University. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 21, co-authored 46 publications receiving 2099 citations. Previous affiliations of Eline Slagboom include Leiden University Medical Center & Loyola University Medical Center.

Papers
More filters
Journal ArticleDOI

Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism

Marine Germain, +61 more
TL;DR: A meta-analysis of genome-wide association studies to identify additional VTE susceptibility genes uncovered unexpected actors of VTE etiology and pave the way for novel mechanistic concepts of V TE pathophysiology.
Journal ArticleDOI

A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22.

TL;DR: A novel common variant on chromosome 7q22 that influences susceptibility to prevalence and progression of OA is identified, since the GPR22 gene encodes a G protein-coupled receptor, this is potentially an interesting therapeutic target.
Journal ArticleDOI

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function

Eleonora Porcu, +93 more
- 07 Feb 2013 - 
TL;DR: A large meta-analysis of genome-wide association studies for serum levels of the highly heritable thyroid function markers TSH and FT4 improves the current knowledge of the regulation of hypothalamic-pituitary-thyroid axis function and the consequences of genetic variation for hypo- or hyperthyroidism.
Journal ArticleDOI

Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans.

TL;DR: It is concluded that hallmarks of age-associated alterations to immune signatures are indeed observed in the general population in people infected with CMV and not those infected with a different persistent herpesvirus.